REGISTER: Hear how Fulcrum Metals (FMET) is board restructuring to support its strategic focus on Canada. Find out at the focusIR Feb Investor Webinar. Sign up here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksPz Cussons Share News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 86.90
Bid: 86.50
Ask: 86.90
Change: 0.40 (0.46%)
Spread: 0.40 (0.462%)
Open: 85.30
High: 87.50
Low: 85.30
Prev. Close: 86.50
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: AstraZeneca breast cancer drugs recommended

Mon, 27th Jun 2022 07:58

(Alliance News) - Stock prices in London are seen opening higher on Monday following a strong close in the US on Friday and a rally across Asian markets, amid gatherings of world leaders and central bankers at separate meetings in Europe this week.

In early company news, Anglo-Swedish drugmaker AstraZeneca said its breast cancer treatments have been recommended for approval in the EU. Personal care products company PZ Cussons said trading is in line with expectations. Money transfers provider Wise said the UK regulator is investigating its chief executive after a tax breach.

IG futures indicate the FTSE 100 index will open 42.39 points higher at 7,251.20. The index closed up 188.36 points, or 2.7%, at 7,208.81 Friday.

AstraZeneca said its Lynparza treatment has been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use for early breast cancer treatment, after positive phase-three results.

Lynparza also demonstrated a statistically significant and clinically meaningful improvement in overall survival, reducing the risk of death by 32% versus placebo, the drugmaker said.

Separately, AstraZeneca said its Enhertu drug also has been recommended for approval in the European Union for patients with breast cancer.

The CHMP based its positive opinion on results from the Destiny-Breast03 phase three trial, which were published in The New England Journal of Medicine.

The trial results showed that Enhertu reduced the risk of disease progression or death by 72% compared with the trastuzumab emtansine drug.

Lynparza was co-developed by AstraZeneca with Merck & Co, while Enhertu was jointly developed with Daiichi Sankyo.

PZ Cussons said trading for the fourth quarter to May 31 has continued to be in line with expectations despite a challenging trading environment.

The maker of products such as Carex, St Tropez and Imperial Leather expects revenue for the financial year of GBP590 million, with full-year like-for-like revenue growth of 3% and fourth-quarter LFL growth of 7%. PZ Cussons recorded revenue of GBP603.3 million in financial 2021.

PZ Cussons said growth continues to be driven primarily by improvements in price mix, with limited impact on volumes. Its expectations for annual adjusted pretax profit are unchanged.

Chief Executive Officer Jonathan Myers said: "The trading environment continues to be challenging, with high input cost inflation and pressures on household budgets. We have plans in place to mitigate the impact of this, as we continue to deliver great value for consumers, whilst also investing behind more premium innovations.

"The recent introduction of our new portfolio brand, Cussons Creations, for the value-conscious consumer, alongside the re-launches of Sanctuary Spa and Imperial Leather, are good examples of such initiatives. They have been well received by customers and have allowed us to secure significant distribution gains."

Wise said the UK Financial Conduct Authority has opened an investigation into CEO Kristo Kaarmann.

Wise said that UK tax collector HM Revenue & Customs in September of last year updated its published list of individuals and businesses receiving penalties for a deliberate default regarding their tax affairs. Kaarmann was included on the list and will remain so for 12 months from its publication.

Following Kaarman's inclusion on the list, the board of Wise had conducted an investigation with the help of external legal counsel and share the findings of this with the FCA.

Wise said Kaarmann intends to cooperate fully with the FCA in its investigation.

Chair David Wells said: "The board takes Kristo's tax default and the FCA's investigation very seriously. After reviewing the matter late last year the board required that Kristo take remedial actions, including appointing professional tax advisors to ensure his personal tax matters are appropriately managed. The board has also shared details of its own findings, assessment and actions with the FCA and will cooperate fully with the FCA as and when they require, while continuing to support Kristo in his role as CEO."

Wall Street ended sharply higher on Friday, with the Dow Jones Industrial Average up 2.7%, S&P 500 up 3.1% and Nasdaq Composite up 3.3%.

In Asia on Monday, the Japanese Nikkei 225 index closed up 1.4%. In China, the Shanghai Composite was up 1.8%, while the Hang Seng index in Hong Kong was up 2.0%. The S&P/ASX 200 in Sydney ended up 1.9%.

World powers on Sunday agreed to ban gold exports from Russia, kicking off a G7 meeting aimed at taking new steps to deplete Moscow's war chest and bolster Ukraine's defences.

US President Joe Biden and his counterparts from the world's most industrialised nations are gathering at Elmau Castle in the German Alps before they continue on to Madrid for talks with NATO partners.

The leaders are seeking to close ranks for Ukraine against Russia's invasion while grappling with the intensifying global fallout of the war.

Ukraine President Volodymyr Zelensky will urge world powers to step up their support for Ukraine when he addresses the G7 summit on Monday

"The G-7 meeting probably has potentially a much greater bearing on Europe right now, than other areas, thanks to the Ukraine/Russia war. European markets piled into the buy-side with the US on Friday after a very mixed week, and with the G-7 springing no surprises thus far, we can expect a positive opening from European markets," said Oanda Markets analyst Jeffery Halley.

Meanwhile, central bank chiefs and economists gather Monday evening at their annual forum in southern Portugal to discuss the best approach to the inflationary challenges exacerbated by Russia's invasion of Ukraine.

Some 200 delegates will attend the ECB Forum on Central Banking at a luxury hotel in Sintra, west of Lisbon, after two years of Covid-imposed virtual gatherings. When ECB President Christine Lagarde last attended this event, it was in her previous role as director general of the International Monetary Fund back in 2014.

Also attending will be Jerome Powell, head of the US Federal Reserve, and Andrew Bailey, governor of the Bank of England. They will be joined by Agustin Carstens, general manager of the Bank for International Settlements, and all four are set to discuss the issues at a seminar on Wednesday, the last day of the forum.

In its annual report released on Sunday, the BIS warned that central banks must not let inflation become entrenched, with the threat of stagflation looming over the global economy.

The pound was quoted at USD1.2270 early Monday, down from USD1.2282 at the London equities close Friday.

The euro was priced at USD1.0565, up from USD1.0549. Against the yen, the dollar was quoted at JPY134.09 in London, lower against JPY135.10.

Brent oil was trading at USD112.88 a barrel Monday morning, down from USD113.44 late Friday. Gold stood at USD1,836.24 an ounce, higher against USD1,830.41.

Monday's economic calendar has US durable goods orders data at 1330 BST. The week picks up pace with a US consumer confidence reading on Wednesday, eurozone unemployment data on Thursday, before inflation readings from the single-currency bloc on Friday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 May 2022 14:35

IN BRIEF: PZ Cussons issues statement on re-election of two directors

PZ Cussons PLC - Manchester-based manufacturer of personal care brands - Issues explanation for why at least 20% of shares cast votes against the re-election of two directors at its annual general meeting in November. Says reason are concerns from a small number of "significant shareholders over remuneration targets and non-executive director share ownership". Firm ensures it has engaged with shareholders on these issues and will continue to do so. "The board continues to keep its remuneration policy under review to ensure it aligns with regulatory requirements and incorporates feedback from stakeholders where practicable," PZ Cussons adds.

Read more
13 Apr 2022 10:35

PZ Cussons backs financial 2022 guidance on third quarter growth

(Alliance News) - PZ Cussons PLC said on Wednesday said it has seen a continued improvement in revenue trends following a decline in the first quarter of its financial year, which ends May 31.

Read more
13 Apr 2022 07:51

LONDON MARKET PRE-OPEN: UK inflation rips to 30-year high; GSK buys

(Alliance News) - Stocks in London were called flat on Wednesday morning as investors digest surging UK inflation data, which follows on the heels of red-hot consumer prices in the US and Germany.

Read more
13 Apr 2022 07:42

PZ Cussons Q3 revenues rise as inflation to have 'limited' impact

(Sharecast News) - Consumer goods group PZ Cussons said third quarter sales rose 8.5% driven by its price-to-discount mix as it maintained volumes during the period.

Read more
6 Apr 2022 15:52

UK earnings, trading statements calendar - next 7 days

Read more
1 Apr 2022 12:11

IN BRIEF: PZ Cussons CEO buys GBP100,000 in shares

PZ Cussons PLC - Manchester-based personal and home care and beauty products - Charmian Myers, an associate of Chief Executive Officer Jonathan Myers, buys 51,175 shares at GBP1.96, worth GBP100,252, on Wednesday.

Read more
31 Mar 2022 15:11

UK dividends calendar - next 7 days

Read more
21 Mar 2022 08:27

PZ Cussons acquires personal care firm Childs Farm for GBP37 million

(Alliance News) - PZ Cussons PLC on Monday said it has acquired Basingstoke, England-based baby and child personal care brand Childs Farm for GBP36.8 million in cash.

Read more
21 Mar 2022 07:53

LONDON MARKET PRE-OPEN: Plus500 enters Japan; Photo-Me enters profit

(Alliance News) - Stock prices in London are seen opening slightly lower on Monday tracking a fall in Asian equity markets, as investors continue to monitor the conflict in Ukraine.

Read more
21 Mar 2022 07:05

Cussons buys Childs Farm for £36.8m

(Sharecast News) - Consumer products giant PZ Cussons said it had bought UK baby and child personal care company Childs Farm for £36.8m in cash.

Read more
3 Mar 2022 16:00

UK dividends calendar - next 7 days

Read more
14 Feb 2022 09:30

LONDON BROKER RATINGS: Goldman Sachs resumes Prudential at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
11 Feb 2022 10:04

Spire Healthcare CFO hospitalised after cycling injury

Spire Healthcare CFO hospitalised after cycling injury

Read more
9 Feb 2022 09:51

PZ Cussons unable to match strong prior year sales in first half

PZ Cussons unable to match strong prior year sales in first half

Read more
9 Feb 2022 08:09

UPDATE 1-PZ Cussons' half-year profit falls as demand softens, costs rise

(Adds CEO quote, details)Feb 9 (Reuters) - Soap maker PZ Cussons said on Wednesday its first-half profit fell from a year earlier as demand for its hand wash and sanitisers dipped from the heights hit during the peak of the COVID-19 pandemic.The m...

Read more

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.